ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Allarity Therapeutics Inc

Allarity Therapeutics Inc (ALLR)

1,61
-0,09
(-5,29%)
Geschlossen 07 Juni 10:00PM
1,62
0,01
(0,62%)
Nach Börsenschluss: 1:59AM

Allarity Therapeutics Inc (ALLR) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
1,61
( -5,29% )
Gebot
1,28
Fragen
1,93
Volumen
157.009
1,56 Tagesbereich 1,715
0,7687 52-Wochen-Bereich 2,35
Marktkapitalisierung
Handelsende
1,70
Handelsbeginn
1,71
Letzte Trade
10
@
1.61
Letzter Handelszeitpunkt
Finanzvolumen
US$ 256.572
VWAP
1,6341
Durchschnittliches Volumen (3 Mio.)
US$ 179.006
Ausgegebene Aktien
15.460.724
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1,87
Gewinn pro Aktie (EPS)
-0,72
Erlöse (LTM)
345k
Nettogewinn (LTM)
-11,25M

Über Allarity Therapeutics Inc

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific comp... Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Tarpon Springs, United States
Gegründet
-
Allarity Therapeutics Inc is listed in the Healthcare sector of the NASDAQ with ticker ALLR. The last closing price for Allarity Therapeutics was US$1,70. Over the last year, Allarity Therapeutics shares have traded in a share price range of US$ 0,7687 to US$ 2,35.

Allarity Therapeutics currently has 15.460.724 shares in issue. The market capitalisation of Allarity Therapeutics is US$24,89 million. Allarity Therapeutics has a price to earnings ratio (PE ratio) of -1.87.

ALLR Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.05-3.012048192771.661.751.552079141.67656128CS
40.138.783783783781.481.83951.342691301.62142976CS
120.2417.51824817521.371.83951.011847741.44526873CS
260.4134.16666666671.21.83950.76871784311.2472943CS
520.7587.20930232560.862.350.768719612461.42087069CS
1561.335485.4545454550.27513.490.113120808451.03213336CS
260-11.57-87.78452200313.1817.450.070218747160.92128911CS

ALLR - Frequently Asked Questions (FAQ)

What is the current Allarity Therapeutics Inc share price?
The current share price of Allarity Therapeutics Inc is US$ 1,61
How many Allarity Therapeutics Inc shares are in issue?
Allarity Therapeutics Inc has 15.460.724 shares in issue
What is the market cap of Allarity Therapeutics Inc?
The market capitalisation of Allarity Therapeutics Inc is USD 24,89M
What is the 1 year trading range for Allarity Therapeutics Inc share price?
Allarity Therapeutics Inc has traded in the range of US$ 0,7687 to US$ 2,35 during the past year
What is the PE ratio of Allarity Therapeutics Inc?
The price to earnings ratio of Allarity Therapeutics Inc is -1,87
What is the cash to sales ratio of Allarity Therapeutics Inc?
The cash to sales ratio of Allarity Therapeutics Inc is 60,5
What is the registered address of Allarity Therapeutics Inc?
The registered address for Allarity Therapeutics Inc is 123 E. Tarpon Ave., Tarpon Springs, Florida, 34689
What is the Allarity Therapeutics Inc website address?
The website address for Allarity Therapeutics Inc is www.allarity.com
Which industry sector does Allarity Therapeutics Inc operate in?
Allarity Therapeutics Inc operates in the Biotechnology & Life Sciences sector

ALLR Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen